Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/02/2003US6657107 Polynucleotides encoding polypeptides having 8-oxoguanine DNA glycosylase activity and uses thereof
12/02/2003US6657105 Monitoring animal for cardiovascular disorders; insert viral gene into animal, monitor animal for cardiovascular disorders
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657056 Compounds for immunotherapy of prostate cancer and methods for their use
12/02/2003US6657055 Detection of modulators of immune response; obtain cell sample, incubate with fusion proteins, monitor cells for immune response
12/02/2003US6657054 Regulated angiogenesis genes and polypeptides
12/02/2003US6657053 Nucleic acid differentially expressed between two nucleic acid samples containing a repertoire of nucleic acids
12/02/2003US6657050 Chimeric viral-neutralizing immunoglobulins
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6657046 Corn rootworm insect inhibitory bioactivity
12/02/2003US6657045 Polyserine domain consisting of 19 contiguous serine residues; modulates the ability of C. parvum sporozoites to attach and invade a host
12/02/2003US6656908 Pesticidal toxins and nucleotide sequences which encode these toxins
12/02/2003US6656906 Hybrid polypeptides with enhanced pharmacokinetic properties
12/02/2003US6656746 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders
12/02/2003US6656728 Fusions of the extracellular domain of a fibroblast growth factor receptor with a heterologous oligomerization domain, such as that contained in an immunoglobulin, to provide potent FGFR antagonists.
12/02/2003US6656726 Viral expression vectors
12/02/2003US6656709 Methods of increasing the production of cobalamins using cob gene expression
12/02/2003US6656708 Splice variant; expression vectors
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656706 Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656700 Isoforms of human pregnancy-associated protein-E
12/02/2003US6656687 Peptide nucleic acid (PNA); in-situ hybridization (ISH); probes for detection of bacteria or eucarya in food, beverage, water, pharmaceutical/personal care/dairy products
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003US6656480 Nucleotide sequences which code polypeptide for use the treatment of mammary gland cancer
12/02/2003US6656479 Protects a mammal against neosporosis
12/02/2003US6656477 43 Kd protein vaccine and method for the production thereof
12/02/2003US6656476 Vaccine against Mumps containing a Jeryl-Lynn virus strain
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003US6656474 Minimal adverse side effects
12/02/2003US6656472 Multi oligosaccharide glycoconjugate bacterial meningitis vaccines
12/02/2003US6656471 Monitoring HLA-Cw7-restricted CTL response; AIDS prevention
12/02/2003US6656469 Treatment of nicotine dependence from tobacco products
12/02/2003US6656468 Such as botulinus antitoxin orally
12/02/2003US6656466 Glycoproteins with controlled sialic acid content produced in mammalian cell culture
12/02/2003US6656465 Antibodies that mimic actions of neurotrophins
12/02/2003US6656430 Affinity binding-based system for detecting particulates in a fluid
12/02/2003US6656133 Transmission assembly for a surgical biopsy device
12/02/2003CA2172165C Human receptor h4-1bb
12/02/2003CA2161804C Purification of plasma proteins
12/02/2003CA2099268C Fusions of a viral protein and a destructive enzyme
12/02/2003CA2085308C Dibasic endoprotease fused to endoplasmic reticulum retention signal and use thereof
12/02/2003CA2051562C Bacillus thuringiensis isolates active against dipteran pests
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/30/2003CA2388445A1 Genetic markers, metabolic markers, and methods for evaluating pathogenicity of strains of e. coli
11/30/2003CA2386752A1 Aerial rosette 1, a gene that controls the time of flowering in plants
11/29/2003WO2003096988A2 Tr4/tr2 response elements
11/29/2003CA2486351A1 Tr4/tr2 response elements
11/27/2003WO2003098225A2 In vitro bioassay for determining the activity of glycoprotein hormones
11/27/2003WO2003098214A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
11/27/2003WO2003098211A1 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein
11/27/2003WO2003098186A2 Bioengineering cotton fiber properties
11/27/2003WO2003097873A2 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications
11/27/2003WO2003097872A2 G - protein coupled receptor marker molecules associated with colorectal lesions
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097843A1 Tumor suppressor locus in prostate cancer
11/27/2003WO2003097842A1 Measure for non-homologous dna recombination process in mammalian cells
11/27/2003WO2003097837A1 Stress-responsive gene specific to root
11/27/2003WO2003097836A1 Method of accumulating arbitrary peptide in plant protein granules
11/27/2003WO2003097834A2 A method for in vitro molecular evolution of protein function
11/27/2003WO2003097833A2 Method for the functional artificial evolution of polynucleotide sequences, recombinant polynucleotides obtained and peptides, polypeptides and proteins coded by same
11/27/2003WO2003097830A1 Method of judging sensibility to imatinib
11/27/2003WO2003097829A1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector
11/27/2003WO2003097821A1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
11/27/2003WO2003097818A1 A method for producing transgenic animal mammary glands secreting human erythropoietin (epo).
11/27/2003WO2003097814A2 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
11/27/2003WO2003097813A2 Regulation of staphylococcus aureus biofilm formation
11/27/2003WO2003097807A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097804A2 Promoter sequences for urocortin ii the use thereof
11/27/2003WO2003097803A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097802A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097801A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097800A2 Cancer-linked gene as target for chemotherapy
11/27/2003WO2003097799A2 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS
11/27/2003WO2003097795A2 Constitutively translocating cell line
11/27/2003WO2003097790A2 Genes and uses thereof to modulate secondary metabolite biosynthesis
11/27/2003WO2003097789A2 Farnesyl diphosphate synthase from pseudomonas aeruginosa
11/27/2003WO2003097695A1 Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
11/27/2003WO2003097694A1 Collagen and method for producing same
11/27/2003WO2003097693A1 Method, use and kit for separating albumin from contaminants in a liquid
11/27/2003WO2003097692A1 Method for albumin purification
11/27/2003WO2003097691A1 Sodium channel regulators and modulators
11/27/2003WO2003097690A2 Pth derivatives resistant to skin proteases
11/27/2003WO2003097689A1 Obg3 fragments inhibiting the conversion of active obg3 into less active obg3 and other compositions for treatment of metabolic disorders
11/27/2003WO2003097688A2 Muteins of placental growth factor type 1, preparation method and application thereof
11/27/2003WO2003097687A2 Neuroprotective polypeptides and methods of use
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097685A1 Clarin polypeptides, polynucleotides encoding same and uses thereof in diagnosis and treatment of usher's syndrome
11/27/2003WO2003097684A2 Card-4 molecules and uses thereof
11/27/2003WO2003097682A1 Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family
11/27/2003WO2003097681A1 Novel transcription mediator proteins dmed21, dmed23, dmed24 and genes thereof
11/27/2003WO2003097680A2 Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same
11/27/2003WO2003097679A1 Cystic echinococcosis protein and uses therefor
11/27/2003WO2003097678A2 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum
11/27/2003WO2003097677A2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus